Benzathine benzylpenicillin

323404007

New Medicines

Penicillin-sensitive bacterial infections including syphilis, rheumatic fever, post-streptococcal glomerulonephritis, erysipelas

Information

New molecular entity
Brancaster Pharma
Not Known

Development and Regulatory status

Approved (Licensed)
None
None
Jul 19 · Approved by MHRA [5].
May 19 · Brancaster now expecting a CHMP opinion in Mar 2019 but no information available on the decision [4].
Mar 18 · Brancaster expects the EU CHMP to issue an opinion on approval of their benzathine benzylpenicillin by end of 2018 [2].

Category

Penicillin antibiotic as 0.6 MIU, 1.2 MIU and 2.4 MIU powder and solvent for suspension for injection
There were 5,288 new diagnoses of syphilis in England in 2015, a 19.9% increase from 4,412 in 2014. This represented the biggest increase of any sexually transmitted infection in 2015 [1].
Penicillin-sensitive bacterial infections including syphilis, rheumatic fever, post-streptococcal glomerulonephritis, erysipelas
Intramuscular